EMR insider plans Rule 144 stock sale

EMR has a Rule 144 notice covering a planned sale of 1,476 shares of common stock through Pershing Advisor Solutions on the NYSE, with an approximate sale date of February 10, 2026 and an aggregate market value of $223,821.00.

Rhea-AI Filing Summary

EMR has a Rule 144 notice covering a planned sale of 1,476 shares of common stock through Pershing Advisor Solutions on the NYSE, with an approximate sale date of February 10, 2026 and an aggregate market value of $223,821.00.

The shares were acquired via restricted stock vesting on February 4, 2025 as compensation. The filing notes 562,000,000 shares of this class outstanding, providing context for the relative size of the proposed sale.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does EMR’s latest Form 144 filing disclose?

The Form 144 filing for EMR discloses a proposed sale of 1,476 shares of common stock. These shares have an aggregate market value of $223,821.00 and are expected to be sold on the NYSE through Pershing Advisor Solutions around February 10, 2026.

How many EMR shares are planned to be sold under this Rule 144 notice?

The notice covers a proposed sale of 1,476 EMR common shares. The filing lists an aggregate market value of $223,821.00, indicating the scale of the transaction relative to the market price and the issuer’s total 562,000,000 shares outstanding.

How were the EMR shares in this Form 144 acquired?

The 1,476 EMR shares in this Form 144 were acquired through restricted stock vesting. The filing states the vesting occurred on February 4, 2025, and identifies the issuer as the source, with the consideration described as compensation rather than a cash purchase.

When are the EMR shares expected to be sold under this Form 144?

The filing lists an approximate date of sale of February 10, 2026. This date reflects when the 1,476 EMR common shares may be sold on the NYSE, subject to Rule 144 conditions and any trading instructions provided to the named broker.

What is the aggregate market value of EMR shares in this Rule 144 filing?

The proposed 1,476 EMR common shares have an aggregate market value of $223,821.00 according to the filing. This figure helps investors gauge the economic size of the intended sale relative to EMR’s capital structure and overall trading liquidity.

How many EMR shares are outstanding compared with this Form 144 sale?

The filing notes 562,000,000 EMR shares outstanding for the relevant class of common stock. Compared with this baseline figure, the planned sale of 1,476 shares represents a very small portion of the issued shares in circulation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/10/2026 - 04:52 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001385208
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	EMERSON ELECTRIC CO
SEC File Number	001-00278
Address of Issuer	8027 FORSYTH BLVD Clayton MISSOURI 63105
Phone	3145532000
Name of Person for Whose Account the Securities are To Be Sold	LEVATICH MATTHEW S
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Pershing Advisor Solutions One Pershing Plaza JERSEY CITY NJ 07399	1476	223821.00	562000000	02/10/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/04/2025	Restricted Stock Vesting	Issuer			1476	02/03/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Mathew S Levatich
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)